Molecular interactions mediating T cell antigen recognition

Annual Review of Immunology

Volumn 21, Issue , 2003, Pages 659-684

  Van Der Merwe, P Anton ^a   Davis, Simon J ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Accessory molecules; Coreceptor; Costimulation; T cell receptor

Indexed keywords

B7 ANTIGEN; CD2 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD48 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SELECTIN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; ABATACEPT; ANTIBODY CONJUGATE; ANTIGEN; CD86 PROTEIN, HUMAN; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN;

ALPHA CHAIN; ANTIBODY AFFINITY; ANTIGEN RECOGNITION; BETA CHAIN; BINDING KINETICS; BINDING SITE; DISULFIDE BOND; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SEQUENCE ANALYSIS; THERMODYNAMICS; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; ELECTRICITY; HUMAN; IMMUNOLOGY; KINETICS; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE;

ANIMALS; ANTIGENS; ANTIGENS, CD; ANTIGENS, CD2; ANTIGENS, CD28; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; ELECTROSTATICS; HUMANS; IMMUNOCONJUGATES; KINETICS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MODELS, MOLECULAR; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 0042971650     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.21.120601.141036     Document Type: Review

References (134)

1. Hennecke J, Wiley DC. 2001. T cell receptor-MHC interactions up close. Cell 104:1-4
2. Rudolph MG, Wilson IA. 2002. The specificity of TCR:pMHC interaction. Curr. Opin. Immunol. 14:52-65
3. Hennecke J, Carfi A, Wiley DC. 2000. Structure of a covalently stabilized complex of a human alpha beta T-cell receptor, influenza HA pepfide and MHC class II molecule, HLA-DR1. EMBO J. 19:5611-24
4. Ding YH, Smith KJ, Garboczi DN, Utz U, Biddison WE, Wiley DC. 1998. Two human T cell receptors bind in a similar diagonal mode to the HLA- A2/Tax peptide complex using different TCR amino acids. Immunity 8:403-11
5. Sim BC, Zerva L, Greene MI, Gascoigne NR. 1996. Control of MHC restriction by TCR Valpha CDR1 and CDR2. Science 273:963-66
6. Rudolph MG, Luz JG, Wilson IA. 2002. Structural and thermodynamic correlates of T cell signaling. Annu. Rev. Biophys. Biomol. Struct. 31:121-49
7. Garcia KC, Degano M, Pease LR, Huang M, Peterson PA, et al. 1998. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279:1166-72
8. Reiser JB, Gregoire C, Damault C, Mosser T, Guimezanes A, et al. 2002. A T cell receptor CDR3 beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. Immunity 16:345-54
9. Ding Y-H, Baker BM, Garboczi DN, Biddison WE, Wiley DC. 1999. Four A6-TCR:peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity 11:45-56
10. Hare BJ, Wyss DF, Osburne MS, Kern PS, Reinherz EL, Wagner G. 1999. Structure, specificity and CDR mobility of a class II restricted single-chain T-cell receptor. Nat. Struct. Biol. 6:574-81
11. Willcox BE, Gao GF, Wyer JR, Ladbury JE, Bell JI, et al. 1999. TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity 10:357-65
12. Boniface JJ, Reich Z, Lyons DS, Davis MM. 1999. Thermodynamics of T cell receptor binding to peptide-MHC: evidence for a general mechanism of molecular scanning. Proc. Natl. Acad. Sci. USA 96:11446-51
13. Garcia KC, Radu CG, Ho J, Ober RJ, Ward ES. 2001. Kinetics and thermodynamics of T cell receptor-autoantigen interactions in murine experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 98:6818-23
14. Mason D. 1998. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19:395-404
15. Manning TC, Schlueter CJ, Brodnicki TC, Parke EA, Speir JA, et al. 1998. Alanine scanning mutagenesis of an alpha beta T cell receptor: mapping the energy of antigen recognition. Immunity 8:413-25
16. Lee PU, Churchill HR, Daniels M, Jameson SC, Kranz DM. 2000. Role of 2CT cell receptor residues in the binding of self- and allo-major histocompatibility complexes. J. Exp. Med. 191:1355-64
17. Baker BM, Turner RV, Gagnon SJ, Wiley DC, Biddison WE. 2001. Identification of a crucial energetic footprint on the alphal helix of human histocompatibility leukocyte antigen (HLA)-A2 that provides functional interactions for recognition by Tax peptide/HLA-A2-specific T cell receptors. J. Exp. Med. 193:551-62
18. Wu LC, Tuot DS, Lyons DS, Garcia KC, Davis MM. 2002. A two-step binding mechanism for T cell receptor recognition of peptide-MHC. Nature 418:552-56
19. Sun ZJ, Kim KS, Wagner G, Reinherz EL. 2001. Mechanisms contributing to T cell receptor signaling and assembly revealed by the solution structure of an ectodomain fragment of the CD3 epsilon gamma heterodimer. Cell 105:913-23
20. Aivazian D, Stern LJ. 2000. Phosphorylation of T cell receptor zeta is regulated by a lipid dependent folding transition. Nat. Struct. Biol. 7:1023-26
21. Gil D, Schamel WW, Montoya M, Sanchez-Madrid F, Alarcon B. 2002. Recruitment of Nck by CD3epsilon reveals a ligand-induced conformational change essential for T cell receptor signaling and synapse formation. Cell 109:901-12
22. Davis MM, Boniface JJ, Reich Z, Lyons D, Hampl J, et al. 1998. Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 16:523-44
23. Manning TC, Kranz DM. 1999. Binding energetics of T-cell receptors: correlation with immunological consequences. Immunol. Today 20:417-22
24. al-Ramadi BK, Jelonek MT, Boyd LF, Margulies DH, Bothwell AL. 1995. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. J. Immunol. 155:662-73
25. Sykulev Y, Vugmeyster Y, Brunmark A, Ploegh HL, Eisen HN. 1998. Peptide antagonism and T cell receptor interactions with peptide-MHC complexes. Immunity 9:475-83
26. Degano M, Garcia KC, Apostolopoulos V, Rudolph MG, Teyton L, Wilson IA. 2000. A functional hot spot for antigen recognition in a superagonist TCR:MHC complex. Immunity 12:251-61
27. Baker MB, Gagnon JS, Biddison EW, Wiley CD. 2000. Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR:peptide/MHC interface: implications for TCR signaling. Immunity 13:475-84
28. Kalergis AM, Boucheron N, Doucey MA, Palmieri E, Goyarts EC, et al. 2001. Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat. Immunol. 2:229-34
29. van der Merwe PA. 2001. The TCR triggering puzzle. Immunity 14:665-68
30. van der Merwe PA. 1999. Leukocyte adhesion: high-speed cells with ABS. Curr. Biol. 9:R419-22
31. Leckband D. 2000. Measuring the forces that control protein interactions. Annu. Rev. Biophys. Biomol. Struct. 29:1-26
32. Zamoyska R. 1994. The CD8 coreceptor revisited: one chain good, two chains better. Immunity 1:243-46
33. Leishman AJ, Naidenko OV, Attinger A, Koning F, Lena CJ, et al. 2001. T cell responses modulated through interaction between CD8 alpha alpha and the nonclassical MHC class I molecule, TL. Science 294:1936-39
34. Gao GF, Tormo J, Gerth UC, Wyer JR, McMichael AJ, et al. 1997. Crystal structure of the complex between human CD8aa and HLA-A2. Nature 387:630-34
35. Kern PS, Teng MK, Smolyar A, Liu JH, Liu J, et al. 1998. Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8 alpha alpha ectodomain fragment in complex with H-2Kb. Immunity 9:519-30
36. Wang JH, Meijers R, Xiong Y, Liu JH, Sakihama T, et al. 2001. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc. Natl. Acad. Sci. USA 98:10799-804
37. Janeway CA Jr. 1992. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev. Immunol. 10:645-74
38. Beyers AD, Spruyt LL, Williams AF. 1992. Molecular associations between the T lymphocyte antigen receptor complex and the surface antigens CD2, CD4 or CD8 and CD5. Proc. Natl. Acad. Sci. USA 89:2945-49
39. Thome M, Duplay P, Guttinger M, Acuto O. 1995. Syk and ZAP-70 mediate recruitment of p561ck/CD4 to the activated T cell receptor/CD3/zeta complex. J. Exp. Med. 181:1997-2006
40. Thome M, Germain V, DiSanto JP, Acuto O. 1996. The p561ck SH2 domain mediates recruitment of CD8/p561ck to the activated T cell receptor/CD3/zeta complex. Eur. J. Immunol. 26:2093-100
41. Xu H, Littman DR. 1993. A kinase-independent function of Lck in potentiating antigen-specific T cell activation. Cell 74:633-43
42. Irvine DJ, Purbhoo MA, Krogsgaard M, Davis MM. 2002. Direct observation of single ligand recognition by T cells. Nature. 419:845-49
43. Devine L, Sun J, Barr MR, Kavathas PB. 1999. Orientation of the Ig domains of CD8 alpha beta relative to MHC class I. J. Immunol. 162:846-51
44. Classon BJ, Brown MH, Garnett D, Somoza C, Barclay AN, et al. 1992. The hinge region of the CD8 alpha chain: structure, antigenicity, and utility in expression of immunoglobulin superfamily domains. Int. Immunol. 4:215-25
45. Boursier JP, Alcover A, Herve F, Laisney I, Acuto O. 1993. Evidence for an extended structure of the T-cell co-receptor CD8 alpha as deduced from the hydrodynamic properties of soluble forms of the extracellular region. J. Biol. Chem. 268:2013-20
46. Casabo LG, Mamalaki C, Kioussis D, Zamoyska R. 1994. T cell activation results in physical modification of the mouse CD8 beta chain. J. Immunol. 152:397-404
47. O'Rourke AM, Rogers J, Mescher MF. 1990. Activated CD8 binding to class I protein mediated by the T-cell receptor results in signalling. Nature 346:187-89
48. Moody AM, Chui D, Reche PA, Priatel JJ, Marth JD, Reinherz EL. 2001. Developmentally regulated glycosylation of the CD8 alpha beta coreceptor stalk modulates ligand binding. Cell 107:501-12
49. Daniels MA, Devine L, Miller JD, Moser JM, Lukacher AE, et al. 2001. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity 15:1051-61
50. Butenhof KJ, Gerken TA. 1993. Structure and dynamics of mucin-like glycopeptides. Examination of peptide chain expansion and peptide-carbohydrate interactions by stochastic dynamics simulations. Biochemistry 32:2650-63
51. Rose MC, Voter WA, Sage H, Brown CF, Kaufman B. 1984. Effects of deglycosylation on the architecture of ovine submaxillary mucin glycoprotein. J. Biol. Chem. 259:3167-72
52. Shogren RL, Jamieson AM, Blackwell J, Jentoft N. 1986. Conformation of mucous glycoproteins in aqueous solvents. Biopolymers 25:1505-17
53. Wyer JR, Willcox BE, Gao GF, Gerth UC, Davis SJ, et al. 1999. T cell receptor and co-receptor CD8αα bind peptide-MHC independently and with distinct kinetics. Immunity 10:219-25
54. Kern P, Hussey RE, Spoerl R, Reinherz EL, Chang HC. 1999. Expression, purification, and functional analysis of murine ectodomain fragments of CD8 alpha alpha and CD8 alpha beta dimers. J. Biol. Chem. 274:27237-43
55. Gao GF, Willcox BE, Wyer JR, Boulter JM, O'Callaghan CA, et al. 2000. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8 alpha alpha. J. Biol. Chem. 275:15232-38
56. Arcaro A, Gregoire C, Bakker TR, Baldi L, Jordan M, et al. 2001. CD8β endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p561ck complexes. J. Exp. Med. 194:1485-95
57. Cammarota G, Scheirle A, Takacs B, Doran DM, Knorr R, et al. 1992. Identification of the CD4 binding site on the β2 domain of HLA-DR molecules. Nature 356:799-801
58. Weber S, Karjalainen K. 1993. Mouse CD4 binds MHC class II with extremely low affinity. Int. Immunol. 5:695-98
59. Xiong Y, Kern P, Chang H, Reinherz E. 2001. T cell receptor binding to a pMHCII ligand is kinetically distinct from and independent of CD4. J. Biol. Chem. 276:5659-67
60. Bosselut R, Kubo S, Guinter T, Kopacz JL, Altman JD, et al. 2000. Role of CD8 beta domains in CD8 coreceptor function: importance for MHC I binding, signaling, and positive selection of CD8+ T cells in the thymus. Immunity 12:409-18
61. Itano A, Cado D, Chan FK, Robey E. 1994. A role for the cytoplasmic tail of the beta chain of CD8 in thymic selection. Immunity 1:287-90
62. Irie HY, Mong MS, Itano A, Crooks ME, Littman DR, et al. 1998. The cytoplasmic domain of CD8 beta regulates Lck kinase activation and CD8 T cell development. J. Immunol. 161:183-91
63. Irie HY, Ravichandran KS, Burakoff SJ. 1995. CD8 beta chain influences CD8 alpha chain-associated Lck kinase activity. J. Exp. Med. 181:1267-73
64. van der Merwe PA, Barclay AN. 1994. Transient intercellular adhesion: the importance of weak protein-protein interactions. Trends Biochem. Sci. 19:354-58
65. Davis SJ, Ikemizu S, Wild MK, van der Merwe PA. 1998. CD2 and the nature of protein interactions mediating cell-cell recognition. Immunol. Rev. 163:217-36
66. Mavaddat N, Mason DW, Atkinson PD, Evans EJ, Gilbert RJ, et al. 2000. Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. J. Biol. Chem. 275:28100-9
67. Punnonen J, Cocks BG, Carballido JM, Bennett B, Peterson D, et al. 1997. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J. Exp. Med. 185:993-1004
68. Dustin ML, Ferguson LM, Chan P, Springer TA, Golan DE. 1996. Visualization of the CD2 interaction with LFA-3 and determination of the two-dimensional dissociation constant for adhesion receptors in a contact area. J. Cell Biol. 132:465-74
69. Dustin ML, Golan DE, Zhu DM, Miller JM, Meier W, et al. 1997. Low affinity interaction of human or rat T cell adhesion molecule CD2 with its ligand aligns adhering membranes to achieve high physiological affinity. J. Biol. Chem. 272:30889-98
70. Doyle C, Strominger JL. 1987. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 330:256-59
71. Norment AM, Salter RD, Parham P, Engelhard VH, Littman DR. 1988. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 336:79-81
72. Zhu B, Davies EA, van der Merwe P, Calvert T, Leckband DE. 2002. Direct measurements of heterotypic adhesion between the cell surface proteins CD2 and CD48. Biochemistry. 41:12163-70
73. Bachmann MF, Barner M, Kopf M. 1999. CD2 sets quantitative thresholds in T cell activation. J. Exp. Med. 190:1383-92
74. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, et al. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197-223
75. Boles KS, Stepp SE, Bennett M, Kumar V, Mathew PA. 2001.2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes. Immunol. Rev. 181:234-49
76. Davis SJ, van der Merwe PA. 1996. The structure and ligand interactions of CD2: implications for T-cell function. Immunol. Today 17:177-87
77. Ikemizu S, Sparks LM, van der Merwe PA, Harlos K, Stuart DI, et al. 1999. Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8-A resolution. Proc. Natl. Acad. Sci. USA 96:4289-94
78. Sun ZY, Dötsch V, Kim M, Li J, Reinherz EL, Wagner G. 1999. Functional glycan-free adhesion domain of human cell surface receptor CD58: design, production and NMR studies. EMBO J. 18:2941-49
79. van der Merwe PA, McNamee PN, Davies EA, Barclay AN, Davis SJ. 1995. Topology of the CD2-CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells. Curr. Biol. 5:74-84
80. Arulanandam ARN, Kister A, McGregor MJ, Wyss DF, Wagner G, Reinherz EL. 1994. Interaction between human CD2 and CD58 involves the major β sheet surface of their respective adhesion domains. J. Exp. Med. 180:1861-71
81. Wang JH, Smolyar A, Tan K, Liu JH, Kim M, et al. 1999. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counter-receptors. Cell 97:791-803
82. Garcia KC, Teyton L, Wilson IA. 1999. Structural basis of T cell recognition. Annu. Rev. Immunol. 17:369-97
83. Davis SJ, Davies EA, Tucknott MG, Jones EY, van der Merwe PA. 1998. The role of charged residues mediating low affinity protein-protein recognition at the cell surface by CD2. Proc. Natl. Acad. Sci. USA 95:5490-94
84. Kim M, Sun ZY, Byron O, Campbell G, Wagner G, et al. 2001. Molecular dissection of the CD2-CD58 counter-receptor interface identifies CD2 Tyr86 and CD58 Lys34 residues as the functional "hot spot". J. Mol. Biol. 312:711-20
85. Chothia C, Janin J. 1975. Principles of protein-protein recognition. Nature 256:705-8
86. Lo Conte L, Chothia C, Janin J. 1999. The atomic structure of protein-protein recognition sites. J. Mol. Biol. 285:2177-98
87. Schwartz JC, Zhang X, Fedorov AA, Nathenson SG, Almo SC. 2001. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 410:604-8
88. Stamper CC, Zhang Y, Tobin JF, Erbe DV, Ikemizu S, et al. 2001. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 410:608-11
89. Sharpe AH, Freeman GJ. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:116-26
90. Carreno BM, Collins M. 2002. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20:29-53
91. Ostrov DA, Shi W, Schwartz JC, Almo SC, Nathenson SG. 2000. Structure of murine CTLA-4 and its role in modulating T cell responsiveness. Science 290:816-19
92. Schwartz JC, Zhang X, Nathenson SG, Almo SC. 2002. Structural mechanisms of costimulation. Nat. Immunol. 3:427-34
93. van der Merwe PA, Davis SJ, Shaw AS, Dustin ML. 2000. Cytoskeletal polarization and redistribution of cell surface molecules during T cell antigen recognition. Semin. Immunol. 12:5-21
94. Collins AV, Brodie DW, Gilbert RJC, Iaboni A, Manso-Sancho R, et al. 2002. The interaction properties of costimulatory molecules revisited. Immunity 17:201-10
95. Ikemizu S, Gilbert RJ, Fennelly JA, Collins AV, Harlos K, et al. 2000. Structure and dimerization of a soluble form of B7-1. Immunity 12:51-60
96. Klug A. 1969. Point groups and the design of aggregates. In Nobel Syposium 11: Symmetry and function of biological systems at the macromolecular level, ed. A Engstrom, B Strandberg, pp. 425-436. Stockholm: Almqvist & Wiksell
97. Zhang X, Schwartz JC, Almo SC, Nathenson SG. 2002. Expression, refolding, purification, molecular characterization, crystallization, and preliminary X-ray analysis of the receptor binding domain of human B7-2. Protein Expr. Purif . 25:105-13
98. van Raaij MJ, Chouin E, van der Zandt H, Bergelson JM, Cusack S. 2000. Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1. 7 A resolution. Strucr Fold. Des. 8:1147-55
99. Metzler WJ, Bajorath J, Fenderson W, Shaw SY, Constantine KL, et al. 1997. Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28. Nat. Struct. Biol. 4:527-31
100. van der Merwe PA, Bodian DL, Daenke S, Linsley P, Davis SJ. 1997. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 185:393-403
101. Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, Peach R. 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793-801
102. Greene JL, Leytze GM, Emswiler J, Peach R, Bajorath J, et al. 1996. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions. J. Biol. Chem. 271:26762-71
103. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, et al. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145-55
104. Kearney ER, Walunas TL, Karr RW, Morton PA, Loh DY, et al. 1995. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1032-36
105. Liang B, Gee RJ, Kashgarian MJ, Sharpe AH, Mamula MJ. 1999. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies. J. Immunol. 163:2322-29
106. Judge TA, Wu Z, Zheng XG, Sharpe AH, Sayegh MH, Turka LA. 1999. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. J. Immunol. 162:1947-51
107. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, et al. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707-18
108. Brodie D, Collins AV, Iaboni A, Fennelly JA, Sparks LM, et al. 2000. LICOS, a primordial costimulatory ligand? Curr. Biol. 10:333-36
109. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, et al. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285:221-27
110. Bromley SK, Iaboni A, Davis SJ, Whitty A, Green JM, et al. 2001. The immunological synapse and CD28-CD80 interactions. Nat. Immunol. 2:1159-66
111. Davis SJ, van der Merwe PA. 2001. The immunological synapse: required for T cell receptor signaling or directing T cell effector function? Curr. Biol. 11:R289-90
112. van der Merwe PA, Davis SJ. 2002. Immunology. The immunological synapse - a multitasking system. Science 295:1479-80
113. Erbe DV, Wang S, Xing Y, Tobin JF. 2002. Small molecule ligands define a binding site on the immune regulatory protein B7.1. J. Biol. Chem. 277:7363-68
114. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, et al. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431-40
115. Corr M, Slanetz AE, Boyd LF, Jelonek MT, Khilko S, et al. 1994. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 265:946-49
116. Sykulev Y, Brunmark A, Jackson M, Cohen RJ, Peterson PA, Eisen HN. 1994. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity 1:15-22
117. Garcia KC, Tallquist MD, Pease LR, Brunmark A, Scott CA, et al. 1997. Alpha beta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. Proc. Natl. Acad. Sci. USA 94:13838-43
118. Alam SM, Travers PJ, Wung JL, Nasholds W, Redpath S, et al. 1996. T-cell-receptor affinity and thymocyte positive selection. Nature 381:616-20
119. Weber S, Traunecker A, Oliveri F, Gerhad W, Karjalainen K. 1992. Specific low-affinity recognition of major histocompatibiliy complex plus peptide by soluble T-cell receptor. Nature 356:793-96
120. Kersh GJ, Kersh EN, Fremont DH, Allen PM. 1998. High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity 9:817-26
121. van der Merwe PA, Barclay AN, Mason DW, Davies EA, Morgan BP, et al. 1994. The human cell-adhesion molecule CD2 binds CD58 with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 33:10149-60
122. van der Merwe PA, Brown MH, Davis SJ, Barclay AN. 1993. Affinity and kinetic analysis of the interaction of the cell-adhesion molecules rat CD2 and CD48. EMBO J. 12:4945-54
123. Brown MH, Boles K, van der Merwe PA, Kumar V, Mathew PA, Barclay AN. 1998. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J. Exp. Med. 188:2083-90
124. Vales-Gomez M, Reyburn HT, Mandelboim M, Strominger JL. 1998. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. Immunity 9:892
125. Maenaka K, Juji T, Nakayama T, Wyer JR, Gao GF, et al. 1999. Killer cell immunoglobulin receptors and T cell receptors bind peptide- major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J. Biol. Chem. 274:28329-34
126. Wright GJ, Puklavec MJ, Willis AC, Hoek RM, Sedgwick JD, et al. 2000. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13:233-42
127. Wild MK, Huang MC, Schulze-Horsel U, van der Merwe PA, Vestweber D. 2001. Affinity, kinetics, and thermodynamics of E-selectin binding to E-selectin ligand-1. J. Biol. Chem. 276:31602-12
128. Labadia ME, Jeanfavre DD, Caviness GO, Morelock MM. 1998. Molecular regulation of the interaction between leukocyte function-associated antigen-1 and soluble ICAM-1 by divalent metal cations. J. Immunol. 161:836-42
129. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134-41
130. Gao GF, Rao Z, Bell JI. 2002. Molecular coordination of alpha beta T-cell receptors and coreceptors CD8 and CD4 in their recognition of peptide-MHC ligands. Trends Immunol. 23:408-13
131. Esnouf RM. 1997. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. Mol. Graph. Model. 15:112-13, 132-34
132. Merritt EA, Murphy MEP. 1994. Raster3D version-2.0: a program for photorealistic molecular graphics. Acta Crystallogr. D 50:869-73
133. Nicholls A, Sharp KA, Honig B. 1991. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11:281-96
134. Lawrence MC, Colman PM. 1993. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234:946-50